Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
06 Februar 2024 - 4:00PM
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO)
announces it has entered into a distribution agreement with
Cardinal Health for its HemeScreen molecular assay products.
Under the agreement,
Cardinal Health will market and distribute Precipio’s HemeScreen
portfolio of molecular assays to its customer base, which comprises
primarily the acute healthcare systems (hospital networks), as well
as reference laboratories and physician owned laboratories. “The
addition of this agreement with Cardinal Health, and alongside
distribution agreements Precipio has with Fisher Healthcare and
McKesson, strengthens our distribution network and positions us for
growth in 2024”, said Ilan Danieli, Precipio’s CEO. “Cardinal
Health is a formidable player in the market, and we are excited to
work with them to deliver value to their customers, and to the
patients they serve”.
About Cardinal
HealthCardinal Health is a distributor of pharmaceuticals,
a global manufacturer and distributor of medical and laboratory
products, and a provider of performance and data solutions for
healthcare facilities. With more than 50 years in business,
operations in more than 30 countries and approximately 48,000
employees globally, Cardinal Health is essential to care.
Information about Cardinal Health is available at
cardinalhealth.com.
About
PrecipioPrecipio has built a platform designed to
eradicate the problem of misdiagnosis by harnessing the intellect,
expertise and technology developed within academic institutions and
delivering quality diagnostic information to physicians and their
patients worldwide, as well as proprietary products that serve
laboratories worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics
and treatment, Precipio offers a new standard of diagnostic
accuracy enabling the highest level of patient care. For more
information, please visit www.precipiodx.com.
Please follow us on LinkedIn, Twitter
@PrecipioDx and on Facebook.
Forward-Looking Statements
This press release contains “forward-looking
statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements contained in this press release
that do not relate to matters of historical fact should be
considered forward-looking statements, including, without
limitation, statements regarding the targets set herein and related
timing.
Except for historical information, statements
about future volumes, sales, growth, costs, cost savings, margins,
earnings, earnings per share, diluted earnings per share, cash
flows, plans, objectives, expectations, growth or profitability are
forward-looking statements based on management’s estimates,
beliefs, assumptions and projections. Words such as “could,” “may,”
“expects,” “anticipates,” “will,” “targets,” “goals,” “projects,”
“intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,”
and variations on such words, and similar expressions that reflect
our current views with respect to future events and operational,
economic and financial performance, are intended to identify such
forward-looking statements. These forward-looking statements are
only predictions based on management’s current expectations. These
statements are neither promises nor guarantees, but involve known
and unknown risks, uncertainties and other important factors that
may cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements expressed or implied by the forward-looking
statements, including, but not limited to, the important factors
discussed under the caption “Risk Factors” in our Annual Report on
Form 10-K for the fiscal year ended December 31, 2022, Quarterly
Report on Form 10-Q for the three months ended September 30, 2023,
and our other reports filed with the U.S. Securities and Exchange
Commission. Any such forward-looking statements represent
management’s estimates as of the date of this press release only.
While we may elect to update such forward-looking statements at
some point in the future, except as required by law, we disclaim
any obligation to do so, even if subsequent events cause our views
to change. These forward-looking statements should not be relied
upon as representing our views as of any date subsequent to the
date of this press release.
Inquiries:
investors@precipiodx.com
+1-203-787-7888 Ext. 523
Precipio (NASDAQ:PRPO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024